Study was terminated due to a business decision to cancel the entire project.

The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.

Inclusion Criteria:

• Have participated and completed a previous study (ROC2-10-078).
• Is Keratoconic

Exclusion Criteria:

• Has any systemic disease affecting ocular health.
• Is using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
• Is not correctable to 20/50 or better in each eye with contact lenses.
• Has greater than Grade 2 slit lamp exam findings.
• Has any atypical scar for a keratoconic or neovascularization within the central 4mm of the cornea. Subjects with minor peripheral corneal scarring that, in the Investigator's judgment, does not interfere with contact lens wear are eligible for this study.
• Has any neovascularization within the central 4mm of the cornea.